https://www.selleckchem.com/GSK-3.html
ng them susceptible to second primary malignancies. Our results may have implications for counseling and consideration for second primary malignancy screening. Patients with ovarian clear cell carcinoma are at increased risk of second primary malignancies, most frequently non-Lynch related. A subset of patients with ovarian clear cell carcinoma may harbor mutations rendering them susceptible to second primary malignancies. Our results may have implications for counseling and consideration for second primary malignancy screening. Young-onset colore